A Randomised Double-Blind Multinational Study to Prevent Major Vascular Events with Ticagrelor Compared to Aspirin (ASA) in Patients with Acute Ischaemic Stroke or TIA [SOCRATES - Acute Stroke Or Transient IsChaemic Attack TReated with Aspirin or Ticagrelor and Patient OutcomES]
-
- STATUS
- Not Recruiting
Updated on 19 February 2024
Summary
The purpose of this study is to assess the prevention of major vascular events in patients treated with ticagrelor 90 mg twice daily compared to ASA 100 mg once daily in patients with acute ischaemic stroke or transient ischaemic stroke.
Description
The purpose of this study is to assess the prevention of major vascular events in patients treated with ticagrelor 90 mg twice daily compared to ASA 100 mg once daily in patients with acute ischaemic stroke or transient ischaemic stroke.
Details
| Condition | Transient Ischaemic Attack, Stroke |
|---|---|
| Age | 100years or below |
| Clinical Study Identifier | TX4450 |
| Last Modified on | 19 February 2024 |
How understandable was the trial content above?
Hard to understand
Easy to understand
Similar trials to consider
Loading...
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.